BROWSE

AUTHOR PROFILE

Browsing by Author Gaber, Hanya

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
  • BB

  • From HIV to COVID-19, Molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development

    • Authors: AbdelMassih, Antoine;  Advisor: -;  Participants: Sedky, Abrar; Shalaby, Ahmed; Shalaby, AlAmira-Fawzia; Yasser, Alia; Mohyeldin, Aya; Amin, Basma; Saleheen, Basma; Osman, Dina; Samuel, Elaria; Abdelfatah, Emmy; Albustami, Eveen; ElGhamry, Farida; Khaled, Habiba; Amr, Hana; Gaber, Hanya; Makhlouf, Ismail; Abdeldayem, Janna; El-Beialy, Jana Waleed; Milad, Karim; Sharkawi, Laila El; Abosenna, Lina; Safi, Madonna G.; AbdelKareem, Mariam; Shershaby, Meryam El (2022)

  • After the discovery of the SARS-CoV-2 variant, Omicron, that sporadically arose in November 2021, it was compared to the Delta variant that was discovered in May 2021 in terms of virulence and transmissibility. While Omicron has shown higher rates of transmission than the other variants, it showed less virulent symptoms with relatively mild disease. The Delta variant, however, has been associated with high virulence causing severe lower respiratory tract symptoms and reduced transmission rate (Kumar et al. 2021). This leaves us wondering; does COVID-19 agree with the trade-off hypothesis?
  • BB

  • The role of miRNAs in viral myocarditis, and its possible implication in induction of mRNA-based COVID-19 vaccines-induced myocarditis

    • Authors: AbdelMassih, Antoine;  Advisor: -;  Participants: Agha, Hala; El-Saiedi, Sonia; El-Sisi, Amal; Shershaby, Meryam El; Gaber, Hanya; Ismail, Habiba-Allah; El-Husseiny, Nadine; Amin, Abeer Reda; ElBoraie, Aly; Ayad, Aya; Menshawey, Esraa; Sefein, Fady; Osman, Ibrahim Ihab; Moursi, Mai; Hanafy, Maram; Abdelaziz, Mariam Sherif; Arsanyous, Mariem Badr; El-Walid, Mariam Khaled-Ibn-; Tawfik, Marwa Gamal; Habib, Menna; Mansour, Mina Ehab; Khattab, Mohamed Ayman; Ashraf, Mirette; Fouda, Raghda (2022)

  • Many lives were lost since the emergence of COVID-19 (coronavirus disease 2019) pandemic in China 2019. The resultant global health crisis has compelled health authorities all over the world to allow emergency authorization to many vaccines before full FDA (Food and drug agency) approval. However, a major setback of such emergency authorization was the rise of unexpected complications.